C. Frank Bennett
for the development of an effective antisense oligonucleotide therapy for children with the neurodegenerative disease spinal muscular atrophy.
Afiliado al momento del premio
Carlsbad, Estados Unidos
Reconocimiento al trabajo con impacto duradero
for the development of an effective antisense oligonucleotide therapy for children with the neurodegenerative disease spinal muscular atrophy.
Carlsbad, Estados Unidos